| 2026年中报 | 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 大容量注射液(元) | 3,559,494,387.00 | 7,484,253,984.00 | 3,749,975,809.00 | 8,911,678,039.00 | 4,667,301,102.00 |
| 非大容量注射液(元) | 4,645,428,984.00 | 8,867,079,106.00 | 4,393,945,959.00 | 10,300,327,368.00 | 5,408,989,284.00 |
| 研发项目(元) | 320,913,067.00 | 1,513,060,754.00 | 636,852,225.00 | 1,894,758,860.00 | 1,386,877,475.00 |
| 营业成本(元) | |||||
| 大容量注射液(元) | 1,584,734,468.00 | 3,329,450,709.00 | 1,646,881,953.00 | 3,550,566,794.00 | 1,761,148,485.00 |
| 非大容量注射液(元) | 2,647,343,984.00 | 5,251,153,642.00 | 2,396,437,408.00 | 5,777,822,294.00 | 3,121,061,955.00 |
| 研发项目(元) | 149,259,105.00 | 530,548,754.00 | 273,144,978.00 | 653,752,620.00 | 304,183,878.00 |
| 毛利(元) | |||||
| 大容量注射液(元) | 1,974,759,919.00 | 4,154,803,275.00 | 2,103,093,856.00 | 5,361,111,245.00 | 2,906,152,617.00 |
| 非大容量注射液(元) | 1,998,085,000.00 | 3,615,925,464.00 | 1,997,508,551.00 | 4,522,505,074.00 | 2,287,927,329.00 |
| 研发项目(元) | 171,653,962.00 | 982,512,000.00 | 363,707,247.00 | 1,241,006,240.00 | 1,082,693,597.00 |
| 毛利率(%) | |||||
| 大容量注射液(%) | 55.48 | 55.51 | 56.08 | 60.16 | 62.27 |
| 非大容量注射液(%) | 43.01 | 40.78 | 45.46 | 43.91 | 42.30 |
| 研发项目(%) | 53.49 | 64.94 | 57.11 | 65.50 | 78.07 |
| 收入构成(%) | |||||
| 大容量注射液(%) | 41.75 | 41.89 | 42.71 | 42.22 | 40.72 |
| 非大容量注射液(%) | 54.49 | 49.64 | 50.04 | 48.80 | 47.19 |
| 研发项目(%) | 3.76 | 8.47 | 7.25 | 8.98 | 12.10 |
| 毛利构成(%) | |||||
| 大容量注射液(%) | 47.65 | 47.47 | 47.11 | 48.19 | 46.30 |
| 非大容量注射液(%) | 48.21 | 41.31 | 44.74 | 40.65 | 36.45 |
| 研发项目(%) | 4.14 | 11.22 | 8.15 | 11.16 | 17.25 |